Chapter 5 Inorganic Molecular Toxicology and Chelation Therapy of Heavy Metals and Metalloids

Advances in Molecular Toxicology

Volumn 2, Issue C, 2008, Pages 123-152

  George, Graham N ^a   Pickering, Ingrid J ^a   Doonan, Christian J ^a   Korbas, Malgorzata ^a   Singh, Satya P ^a   Hoffmeyer, Ruth E ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANION; ARSENIC; ARSENIC TRIOXIDE; COPPER; GLUTATHIONE PEROXIDASE; HEAVY METAL; INORGANIC COMPOUND; MERCURY; METALLOID; METHYLMERCURY; OXYANION; PENTETIC ACID; SELENIUM; SELENOCYSTEINE; SELENOMETHIONINE; SELENOPROTEIN; SUCCIMER; THIOMOLYBDIC ACID; THIOREDOXIN REDUCTASE; UNCLASSIFIED DRUG; UNITHIOL;

CHELATION THERAPY; CHEMISTRY; HUMAN; INFLUENZA; MOLECULAR MIMICRY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; ROENTGEN SPECTROSCOPY; WATER SUPPLY; WILSON DISEASE;

EID: 76449100585     PISSN: 18720854     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1872-0854(07)02005-X     Document Type: Review

References (94)

1. George G.N., and Pickering I.J. X-ray absorption spectroscopy in biology and chemistry. In: Tsakanov V., and Wiedemann H. (Eds). Brilliant Light in Life and Materials Sciences XAS Review (2007), Springer, Dordrecht, NL 97-119
2. Harris H.H., Pickering I.J., and George G.N. The chemical form of mercury in fish. Science 381 (2003) 1203
3. Pickering I.J., George G.N., van Fleet-Stalder V., Chasteen T.G., and Prince R.C. X-ray absorption spectroscopy of selenium-containing amino acids. J. Biol. Inorg. Chem. 4 (1999) 791-794
4. Pickering I.J., Prince R.C., Salt D.E., and George G.N. Quantitative chemically-specific imaging of selenium transformation in plants. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 10717-10722
5. Pickering I.J., Gumaelius L., Harris H.H., Prince R.C., Hirsch G., Banks J.A., Salt D.E., and George G.N. Localizing the biochemical transformations of arsenate in a hyperaccumulating fern. Environ. Sci. Technol. 40 (2006) 5010-5014
6. Dillon C.T., Lay P.A., Kennedy B.J., Stampfl A., Anton P.J., Cai Z., Ilinski P., Rodrigues W., Legnini D.G., Lai B., and Maser J. Hard X-ray microprobe studies of chromium(VI)-treated V79 Chinese hamster lung cells: intracellular mapping of the biotransformation products of a chromium carcinogen. J. Biol. Inorg. Chem. 7 (2002) 640-645
7. x] complexes. Inorg. Chem. 31 (1992) 5343-5344
8. Clarkson T.W., and Magos L. The toxicology of mercury and its compounds. Crit. Rev. Toxicol. 36 (2006) 609-662
9. Carr H.S., George G.N., and Winge D.R. Yeast Cox11, a protein essential for cytochrome c oxidase assembly, is a Cu(I)-binding protein. J. Biol. Chem. 277 (2002) 31237-31242
10. Liu T., Ramesh A., Ma Z., Ward S.K., Zhang L., George G.N., Talaat A.M., Sacchettini J.C., and Giedroc D.P. CsoR is a novel Mycobacterium tuberculosis copper-sensing transcriptional regulator. Nat. Chem. Biol. 3 (2007) 60-68
11. Brown K.R., Keller G., Pickering I.J., Harris H.H., George G.N., and Winge D.R. The structures of the cuprous thiolate clusters of the Ace1 and Mac1 transcriptional activators. Biochemistry 41 (2002) 6467-6469
12. Ralle M., Cooper M.J., Lutsenko S., and Blackburn N.J. The Menkes disease protein binds copper via Novel 2-coordinate Cu(I)-cysteinates in the N-terminal domain. J. Am. Chem. Soc. 120 (1998) 13525-13526
13. Xiao Z., Loughlin F., George G.N., Howlett G.J., and Wedd A.G. The C-terminal domain of the membrane copper transporter Ctr1 from Saccharomyces cerevisiae binds four Cu(I) ions as a cuprous-thiolate polynuclear cluster. Sub-femtomolar Cu(I) affinity of three proteins involved in copper trafficking. J. Am. Chem. Soc. 126 (2004) 3081-3090
14. 2). Organometallics 13 (1994) 3038-3053
15. Hornig M., Chian D., and Lipkin W.I. Neurotoxic effects of postnatal thimerosal are mouse strain dependent. Mol. Psych. 9 (2004) 833-845
16. Schwendtner K., and Kolitsch U. Octahedral as in M+ arsenates-architecture and seven new members. Acta Cryst. B63 (2007) 205-215
17. Allen F.H., Kennard O., and Watson D.G. Crystallographic databases: search and retrieval of information from the Cambridge Structural Database. Struct. Correl. 1 (1994) 71-110
18. Fujinami R.S., Oldstone M.B., Wroblewska Z., Frankel M.E., and Koprowski H. Molecular mimicry in virus infection: crossreaction of measles virus phosphoprotein or of Herpes simplex virus protein with human intermediate filaments. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 2346-2350
19. Johnson M.A., and Pinto B.M. Molecular mimicry of carbohydrates by peptides. Aust. J. Chem. 55 (2002) 13-25
20. Wetterhahn-Jennette K. The role of metals in carcinogenesis: biochemistry and metabolism. Env. Health Persp. 40 (1981) 233-252
21. Bridges C.C., and Zalups R.K. Moleculer and ionic mimicry and the transport of toxic metals. Toxicol. Appl. Pharmacol. 204 (2005) 274-308
22. Peter A.L., and Viraraghavan T. Thallium: a review of public health and environmental concerns. Environ. Int. 31 (2005) 403-501
23. Tsai Y.-T., Huang C.-C., Kuo H.-C., Wang H.-W., Shen W.-S., Shih T.-S., and Chu N.S. Central nervous system effects in acute thallium poisoning. Neurotoxicology 27 (2006) 291-295
24. 201Tl) in the rat Arch. Toxicol. 7 (Suppl. 1) (Dis. Metab. Reprod. Toxic Response Drugs Other Chem.) (1984), 446-450.
25. Jung C., and Rothstein A. Arsenate uptake and release in relation to the inhibition of transport and gylcolysis in yeast. Biochem. Pharmacol. 14 (1965) 1093-1112
26. Kenney L.J., and Kaplan J.H. Arsenate substitutes for phosphate in the human red cell sodium pump and anion exchanger. J. Biol. Chem. 263 (1988) 7954-7960
27. Kim Y.J., Kim J.H., Lee C.E., Mok Y.G., Choi J.S., Shin H.S., and Hwang S. Expression of yeast transcriptional activator MSN1 promotes accumulation of chromium and sulfur by enhancing sulfate transporter level in plants. FEBS Lett. 580 (2006) 206-210
28. Markovich D., Regeer R.R., Kunzelmann K., and Dawson P.A. Functional characterization and genomic organization of the human Na+-sulfate cotransporter hNaS2 gene (SLC13A4). Biochem. Biophys. Res. Commun. 326 (2005) 729-734
29. Dudev T., and Lim C. Oxyanion selectivity in sulfate and molybdate transport proteins: an ab initio/CDM study. J. Am. Chem. Soc. 126 (2004) 10296-10305
30. Riesco-Eizaguirre G., and Santisteban P. A perspective view of sodium iodide symporter research and its clinical implications. Eur. J. Endocrinol. 155 (2006) 495-512
31. Zuckier L.S., Dohan O., Li Y., Chang C.J., Carrasc N., and Dadachova E. Kinetics of perrhenate uptake and comparative biodistribution of perrhenate, pertechnetate, and iodide by NaI symporter-expressing tissues in vivo. J. Nucl. Med. 45 (2004) 500-507
32. Taylor N.J., Wong Y.S., Chieh P.C., and Carty A.J. Syntheses, X-ray crystal structure, and vibrational spectra of l-cysteinato(methyl)mercury(II) monohydrate. J. Chem. Soc., Dalton Trans. 5 (1975) 438-442
33. Simmons-Willis T.A., Koh A.S., Clarkson T.W., and Ballatori N. Transport of a neurotoxicant by molecular mimicry: the methylmercury-l-cysteine complex is a substrate for human L-type large neutral amino acid transporter (LAT) 1 and LAT2. Biochem. J. 367 (2002) 239-246
34. Hodgkin E.E., and Richards W.G. Molecular similarity based on electrostatic potential and electric field. Int. J. Quantum Chem.: Quantum Biol. Symp. 14 (1987) 105-110
35. Rosenthal G.A. The biological effects and mode of action of l-canavanine, a structural analogue of l-arginine. Quart. Rev. Biol. 52 (1977) 155-178
36. Hoffmeyer R., Singh S.P., Doonan C.J., Ross A.R.S., Hughes R.J., Pickering I.J., and George G.N. Molecular mimicry in mercury toxicology. Chem. Res. Toxicol. 19 (2006) 753-759
37. Hoffmeyer R., Singh S.P., Doonan C.J., Ross A.R.S., Hughes R.J., Pickering I.J., and George G.N. More on molecular mimicry in mercury toxicology. Chem. Res. Toxicol. 19 (2006) 1118-1120
38. Galier J. Arsenic-selenium and mercury-selenium bonds in biology. Coord. Chem. Rev. 251 (2007) 234-254
39. Moxon A.L. The effect of arsenic on the toxicity of seleniferous grains. Science 88 (1938) 81
40. Gailer J., George G.N., Pickering I.J., Prince R.C., Ringwald S.C., Pemberton J., Glass R.S., Younis H.S., DeYoung D.W., and Aposhian H.V.A. A metabolic link between arsenite and selenite: the seleno-bis(S-glutathionyl) arsinium ion. J. Am. Chem. Soc. 122 (2000) 4637-4639
41. Manley S., George G.N., Pickering I.J., Prince R.C., Glass R.S., Prenner E.J., Yamdagni R., Wu Q., and Gailer J. The seleno-bis(S-glutathionyl) arsinium ion is assembled in erythrocyte lysate. Chem. Res. Toxicol. 19 (2006) 601-607
42. - after intravenous injection of rabbits with arsenite and selenite. Chem. Res. Toxicol. 15 (2002) 1466-1471
43. Leslie E.M., Haimeur A., and Waalke M.P. Arsenic transport by the human multidrug resistance protein 1 (MRP1/ABCC1): evidence that a tri-glutathione conjugate is required. J. Biol. Chem. 279 (2004) 32700-32708
44. Lee T.-C., Ho I.-C., Lu W.-J., and Huang J.-d. Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line. J. Biol. Chem. 281 (2006) 18401-18407
45. Anke M., Hennig A., Grun M., Partschefeld M., Groppel B., and Ludke Arch Tierernahr H. Arsenic - a new essential trace element. Arch. Tierernahr. 10 (1976) 742-743
46. Nielsen F.H. New essential trace elements for the life sciences. Biol. Trace Elem. Res. 26-27 (1990) 599-611
47. Behne D., and Kyriakopoulos A. Mammalian selenium-containing proteins. Annu. Rev. Nutr. 21 (2001) 453-473
48. Clark L.C., Dalkin B., Krongrad A., Combs Jr. G.F., Turnbull B.W., Slate E.H., Witherington R., Herlong J.H., Janosko E., Carpenter D., Borosso C., Falk S., and Rounder J. Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. Br. J. Urol. 81 (1998) 730-734
49. Kune G., and Watson L. Colorectal cancer protective effects and the dietary micronutrients folate, methionine, vitamins B6, B12, C, E, selenium, and lycopene. Nutr. Cancer 56 (2006) 11-21
50. Della Rovere F., Granata A., Familiari D., Zirilli A., Cimino F., and Tomaino A. Histamine and selenium in lung cancer. Anticancer Res. 26 (2006) 2937-2942
51. Grau M.V., Rees J.R., and Baron J.A. Chemoprevention in gastrointestinal cancers: current status. Basic Clin. Pharmacol. Toxicol. 98 (2006) 281-287
52. Li W., and Beck M.A. Selenium deficiency induced an altered immune response and increased survival following influenza A/Puerto Rico/8/34 infection. Exper. Biol. Med. 232 (2007) 412-419
53. Dhar R.Kr., Biswas B.Kr., Samanta G., Mandal B.Kr., Chakraborti D., Roy S., Jafar A., Islam A., Ara G., Kabir S., Wadud Khan A., Akther Ahmed S., and Abdul Hadi S. Groundwater arsenic calamity in Bangladesh. Curr. Sci. 73 (1997) 48-59
54. Abedin Md.J., Cresser M.S., Meharg A.A., Feldmann J., and Cotter-Howells J. Arsenic accumulation and metabolism in rice (Oryza sativa L.). Environ. Sci. Technol. 36 (2002) 962-968
55. Abedin Md.J., Cotter-Howells J., and Meharg A.A. Arsenic uptake and accumulation in rice (Oryza sativa L.) irrigated with contaminated water. Plant Soil 240 (2002) 311-319
56. van Geen A., Zheng Y., Cheng Z., He Y., Dhar R.K., Garnier J.M., Rose J., Seddique A., Hoque M.A., and Ahmed K.M. Impact of irrigating rice paddies with groundwater containing arsenic in Bangladesh. Sci. Total Environ. 367 (2006) 769-777
57. A.M. Sancha, D. Rodriguez, F. Vega, S. Fuentes, A.M. Salazar, V. Hernan, V. Moreno, A.M. Baron, Exposure to arsenic of the Atacameno population in northern Chile, IAHS Publication, 233, (Assessing and Managing Health Risks from Drinking Water Contamination), 141-146 (1995).
58. Gradecka D., Palus J., and Wasowicz W. Selected mechanisms of genotoxic effects of inorganic arsenic compounds. Int. J. Occup. Med. Environ. Health 14 (2001) 317-328
59. Spallholz J.E., Boylan L.M., and Ruaman M.M. Environmental hypothesis: is poor dietary selenium intake an underlying factor for arsenicosis and cancer in Bangladesh and West Bengal, India?. Sci. Total Environ. 323 (2004) 21-32
60. http://www.bangladesh-selenium.org/
61. Chen Y., Hall M., Graziano J.H., Slavkovich V., van Geen A., Parvez F., and Ahsan H.A. Prospective study of blood selenium levels and the risk of arsenic-related premalignant skin lesions. Cancer Epidemiol. Biomarkers Prev. 16 (2007) 207-213
62. Kraus R.J., and Ganther H.E. Synergistic toxicity between arsenic and methylated selenium compounds. Biol. Trace Elem. Res. 20 1-2 (1989) 105-113
63. Obermeyer B.D., Palmer I.S., Olson O.E., and Halvarson A.W. Toxicity of trimethylselenonium chloride in the rat with and without arsenite. Toxicol. Appl. Pharmacol. 20 (1971) 135-146
64. R. Andrahennadi, I.J. Pickering, unpublished observations.
65. Gailer J., George G.N., Pickering I.J., Madden S., Prince R.C., Yu E.Y., Denton M.B., Younis H.S., and Aposhian H.V. Structural basis of the antagonism between inorganic mercury and selenium in mammals. Chem. Res. Toxicol. 13 (2000) 1135-1142
66. Martoja R., and Berry J.P. Identification of tiemannite as a probable product of demethylation of mercury by selenium in cetaceans. A complement to the scheme of the biological cycle of mercury. Vie Milieu 30 (1980) 7-10
67. Watanabe C. Tohoku. J. Exp. Med. 196 (2002) 71-77
68. Magos L. Overview on the protection given by selenium against mercurials. In: Suzuki K., Imura N., and Clarkson T.W. (Eds). Advances in Mercury Toxicology (1991), Plenum Press, New York 289-298
69. Heinz G.H., and Hoffman D.J. Methylmercury chloride and selenomethionine interactions on health and reproduction in mallards. Environ. Toxicol. Chem. 17 (1998) 139-145
70. Ralston C.R., Blackwell III J.L., and Ralston N.C.V. Effects of dietary selenium and mercury on house crickets (Acheta domesticus L.): implications of environmental co-exposures. Environ. Bioindicators 1 (2006) 98-109
71. El-Begearmi M.M., Ganther H.E., and Sunde M.L. Dietary interaction between methylmercury, selenium, arsenic, and sulfur amino acids in Japanese quail. Poult. Sci. 61 (1982) 272-279
72. Naganuma A., and Imura N. Methylmercury binds to a low molecular weight substance in rabbit and human erythrocytes. Toxicol. Appl. Pharmacol. 47 (1979) 613-616
73. M. Korbas, A.J. Percy, G.N. George, J. Gailer (unpublished observations).
74. N.N. Greenwood, A. Earnshaw, Chemistry of the Elements, 2nd edition, Butterworth-Heinemann, Oxford, UK, 1997.
75. Ord M.G., and Stocken L.A. A contribution to chemical defense in World War II. Trends Biochem. Sci. 25 (2000) 253-256
76. George G.N., Prince R.C., Gailer J., Buttigieg G.A., Denton M.B., Harris H.H., and Pickering I.J. Mercury binding to the chelation therapy agents DMSA and DMPS, and the rational design of custom chelators for mercury. Chem. Res. Toxicol. 17 (2004) 999-1006
77. Aposhian H.V., Maiorino R.M., Gonzalez-Ramirez D., Zuniga-Charles M., Xu Z., Hurlbut K.M., Junco-Munoz P., Dart R.C., and Aposhian M.M. Mobilization of heavy metals by newer, therapeutically useful chelating agents. Toxicology 97 (1995) 23-38
78. Campbell J.R., Clarkson T.W., and Omar M.D. The therapeutic use of 2,3-dimercaptopropane-1-sulfonate in two cases of inorganic mercury poisoning. J. Am. Med. Assoc. 256 (1986) 3127-3130
79. Gonzalez-Ramizez D., Maiorino R.M., Zuniga-Charles M., Xu Z., Hurlbut K.M., Junco-Munoz P., Aposhian M.M., Dart R.C., Diaz Gama J.H., Echeverra D., Woods J.S., and Aposhian H.V. Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans: II. urinary mercury, porphyrins and neurobehavioral changes of dental workers in monterrey, Mexico. J. Pharmacol. Exp. Ther. 272 (1995) 264-274
80. Garza-Ocanas L., Torres-Alanis O., Pineyro-Lopez, and A A. Urinary mercury in twelve cases of cutaneous mercurous chloride (calomel) exposure: effect of sodium 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy. J. Toxicol. Clin. Toxicol. 35 (1997) 653-655
81. Böse-O'Reilly S., Drasch S., Beinhoff C., Maydla S., Voskob M.R., Roidera G., and Dzajaa D. The Mt. Diwata study on the Philippines 2000 - treatment of mercury intoxicated inhabitants of a gold mining area with DMPS (2,3-dimercapto-1-propane-sulfonic acid, Dimaval®). Sci. Total Environ. 307 (2003) 71-82
82. Pfab R., Mueckter H., Roider G., and Zilker T. Clinical course of severe poisoning with thiomersal. J. Toxicol. Clin. Toxicol. 34 (1996) 453-460
83. Q. Zeng, C. Stalhandske, M.C. Anderson, R.A. Scott, A.O. Summers, The Core Metal-Recognition Domain of MerR, Biochemistry, 37, (1998) 15885-15895.
84. n+1,2n+4][2n+1]metacyclophanes. J. Chem. Soc. Perkin Trans. 1 (1976) 1691-1693
85. Mascal M., Kerdelhué J.-L., Blake A.J., and Cooke P.A. S-cylindrophanes: from metal tweezers to metal sandwiches. Angew. Chem. Int. Ed. 38 (1999) 1968-1971
86. Sunderman Jr. F.W. Diethyldithiocarbamate therapy of thallotoxicosis. Am. J. Med. Sci. 253 (1967) 209-220
87. Kamerbeek H.H., Rauws A.G., Ten Ham M., and Van Heijst A.N.P. Dangerous redistribution of thallium by treatment with sodium diethyldithiocarbamate. Acta Med. Scand. 189 (1971) 149-154
88. Kodama H., Sato E., Gu Y.-H., Shiga K., Fujisawa C., and Kozuma T. Effect of copper and diethyldithiocarbamate combination therapy on the macular mouse, an animal model of Menkes disease. J. Inherit. Metab. Dis. 28 (2005) 971-978
89. Shyamal D.K., and Ray K. Wilson's disease: an update. Nature Clin. Pract. Neurol. 2 (2006) 482-493
90. Klein D., Arora U., Lichtmannegger J., Finckh M., Heinzmann U., and Summer K.-H. Tetrathiomolybdate in the treatment of acute hepatitis in an animal model for Wilson disease. J. Hepatol. 40 (2004) 409-416
91. Sas B. Secondary copper deficiency in cattle caused by molybdenum contamination of fodder: a case history. Vet. Hum. Toxicol. 31 (1989) 29-33
92. George G.N., Pickering I.J., Harris H.H., Gailer J., Klein D., Lichtmannegger J., and Summer K.-H. Tetrathiomolybdate causes formation of hepatic copper-molybdenum clusters in an animal model of Wilson's disease. J. Am. Chem. Soc. 125 (2003) 1704-1705
93. Brown M.J., Willis T., Omalu B., and Leiker R. Deaths resulting from hypocalcemia after administration of edetate disodium 2003-2005. Pediatrics 118 (2006) e534-e536
94. Fukuda S. Chelating agents used for plutonium and uranium removal in radiation emergency medicine. Curr. Med. Chem. 12 (2005) 2765-2770